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E. Annie Trent, BS, Eugene M. Langan, III, MD, and Jerry R. Youkey, MD, Greenville, SC
Background:When reporting standards for successful lower extremity revascularization were established, it was assumed
that arterial reconstruction, patency, and limb salvage would correlate with the ultimate goal of therapy: improved
functional performance. In reality, factors determining improvement of ambulation and maintenance of independent
living status after revascularization have been poorly studied. The purpose of this study was to assess the important
determinants of functional outcome for patients after intervention for critical limb ischemia.
Methods: The results of 1000 revascularized limbs from 841 patients were studied. Indications were rest pain, 41.1%;
ischemic ulceration, 35.6%; gangrene, 23.3%; infrainguinal, 70.9%; aortoiliac, 24.2%; and both, 4.9%. Treatment was by
endovascular intervention, 35.5%; open surgery, 61.7%; and both, 2.8%. Patient were mean age of 68  12 years, and
56.6% were men, 74.7% were white, 54.2% had diabetes mellitus, 67% were smokers, 13.4% had end-stage renal disease
and were on dialysis, and 36% had prior vascular surgery. Patients were treated with conventional therapy by
fellowship-trained vascular specialists at a single center and were analyzed according to the type of intervention, the
arterial level treated, age, race, gender, presentation, the presence of diabetes, smoking history, end-stage renal disease,
coronary disease, hypertension, hyperlipidemia, obesity, chronic obstructive pulmonary disease, previous stroke, demen-
tia, prior vascular surgery, preoperative ambulatory status, limb loss<1 year of treatment, and independent living status.
The technical outcomes of reconstruction patency and limb salvage as well as the functional outcomes of survival,
maintenance of ambulation, and independent living status were measured for each variable using Kaplan-Meier life-table
analysis, and differences were assessed using the log-rank test. A Cox proportional hazards model was used to assess
independent predictors of outcome and obtain adjusted hazard ratios and 95% confidence intervals.
Results: At 5 years, 72.4% of the entire cohort had a patent reconstruction and 72.1% had an intact limb. Overall 5-year
functional outcomes were 41.9% for survival, 70.6% for maintenance of ambulation, and 81.3% for independent living
status. Outcome was not significantly affected by the type of treatment (endovascular or open surgery) or by the level of
disease treated (aortoiliac, infrainguinal, or both). The most important independent, statistically significant predictors of
particularly poor functional outcome were impaired ambulatory ability at the time of presentation (70% 5-year mortality,
hazard ratio, 3.34; 39.5% failure to eventually ambulate, hazard ratio, 2.83; 30% loss of independent living status, hazard
ratio, 7.97), and the presence of dementia (73% late mortality, hazard ratio, 1.57; 41.2% failure to eventually ambulate,
hazard ratio, 2.20; 46.4% loss of independent living status, hazard ratio, 5.44). These factors were even more predictive
than limb amputation alone.
Conclusion: Functional outcome for patients undergoing intervention for critical limb ischemia is not solely determined
by the traditional measures of reconstruction patency and limb salvage, but also by certain intrinsic patient comorbidities
at the time of presentation. These findings question the benefit of our current approach to critical limb ischemia in
functionally impaired, chronically ill patients—patients who undoubtedly will be more prevalent as our population ages.
(J Vasc Surg 2006;44:747-56.)In the case of surgical intervention, favorable outcome
is determined by preconceived definitions of success. For
example, surgical intervention to treat cancer might be
considered a success if the tumor were removed and the
patient experienced long-term survival with no recurrent
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critical limb ischemia were originally established, success
was defined as patency of the vascular reconstruction and
limb salvage. It was assumed that these important objec-
tives would correlate with the unstated ultimate goal,
namely, preservation of ambulation, maintenance of inde-
pendence, and perhaps survival.
Over the years, however, we have observed that arterial
reconstruction patency does not necessarily correlate with
limb salvage. Indeed, measured limb salvage rates often
exceed patency rates.1 The counterintuitive nature of this
finding raises an interesting question: Does limb salvage
alone consistently predict successful functional outcome?
Although some reports have demonstrated the advantages
of limb salvage compared with major limb amputation by
using end points important to vascular surgeons,2-6 the
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functional end points of ambulation maintenance and pres-
ervation of independence, has not been studied.
The number of older patients is expected to increase with
the coming of the baby-boomers, and it would be helpful to
know which preoperative variables influence ultimate func-
tional outcome in addition to limb salvage. The purpose of
this study therefore was to determine the importance of
limb salvage on ultimate functional outcome and to assess
other important determinants of functional outcome for
patients after intervention for critical limb ischemia.
METHODS
The postoperative functional outcome of 841 patients
undergoing 1000 consecutive lower extremity vascular in-
terventions between January 1998 and May 2004 by the
vascular surgery teaching service of the Greenville Hospital
System University Medical Center (GHSUMC) in Green-
ville, South Carolina was analyzed using 22 perioperative
variables, including limb loss 1 year of intervention.
Seven fellowship-trained vascular surgeons and one inter-
ventional fellowship-trained vascular internist on the teach-
ing service performed all interventions to treat critical,
limb-threatening ischemia, defined as ischemic rest pain,
ulceration, and gangrene, with an ankle pressure 50 to 70
mm or a toe pressure 30 mm.
The type of intervention was determined by the
presenting patient scenario and by the clinical judgment
of the attending physician. The 21 perioperative vari-
ables analyzed in addition to limb salvage included age,
race, gender, presentation (rest pain, ulceration, gan-
grene), the presence of diabetes mellitus, tobacco status,
chronic renal failure and end-stage renal disease, the
presence of coronary artery disease (high risk by the
Eagle criteria),7 history of hypertension, history of hy-
perlipidemia, the presence of obesity (body mass index of
30 kg/m2), history of chronic obstructive pulmonary
disease (COPD), previous stroke, history of previous
cerebrovascular disease, the presence of dementia, his-
tory of a vascular procedure, ambulatory status at pre-
sentation, independent living status at presentation,
the type of procedure performed (endovascular, open,
both), the level of arterial disease treated (aortoiliac,
infrainguinal, both), and the type of intervention by the
level of arterial disease treated (aortoiliac– endovascular,
aortoiliac–open, aortoiliac–and both, infrainguinal–
endovascular, infrainguinal–open, infrainguinal–both,
both–endovascular, both–open, both–both).
Preoperative ambulatory status was characterized as
ambulatory (independent ambulation out of house),
ambulatory/homebound (ambulatory in the home only),
or nonambulatory/transfer (eg, uses legs to transfer from
bed to chair or from the chair to the commode). In each
case, impaired ambulatory status was determined by phys-
ical conditions that were thought to be independent of
their vascular disease. Impaired ambulatory status was de-
fined as the patient’s functional status immediately before
the development of vascular symptoms. With this defini-tion, ambulatory status was usually a function of other
medical comorbidities such as arthritis, cerebrovascular and
cardiovascular disease, or advanced age.
Preoperative living status was characterized as indepen-
dent, defined as living in an independent dwelling without
external assistance; or non-independent, defined as living in
an assisted living environment or a private residence with
external assistance for activities of daily living. As with
ambulatory status, living status was determined immedi-
ately before the development of vascular symptoms.
Postoperative functional outcome measures included
mortality; change in ambulatory function, defined as the
permanent postoperative change, despite full recovery from
the revascularization, in ambulatory classification (eg,
ambulatory to nonambulatory/transfer, ambulatory to
nonambulatory/bedridden, or nonambulatory/transfer
to nonambulatory/bedridden); and a decline in indepen-
dent living status, defined as a permanent change to an
assisted living residence or incorporation of permanent help
into the postoperative domicile to enhance functions of
daily living. Short-term assisted living during recovery was
not considered a loss of independence.
To frame the postoperative functional outcome mea-
sures within the context of the traditional measures of
technical success, secondary arterial reconstruction patency
(the percentage of limbs with a patent arterial reconstruc-
tion) and limb salvage were obtained. Patency, as previ-
ously described,8 was determined clinically, in the vascular
lab, or by arteriography.
The lower extremity database and data collection
process. Since 1992 a prospective vascular registry of all
cases performed on the GHSUMC Vascular Surgery Ser-
vice has been maintained. Since 1998, however, the year
our endovascular programwas initiated, a subset of patients
with lower extremity peripheral arterial disease have been
closely scrutinized and actively followed with Institutional
Review Committee approval. Each procedure is entered on
an Excel spreadsheet (Microsoft Corp, Redmond, Wash).
Preoperative demographics are obtained at presentation
and entered into the database. Functional information
(ambulatory status and living situation) and also the lower
extremity grading system (LEGS) score are included.
Follow-up has been recorded at each follow-up visit. For
patients receiving open infrainguinal bypass, follow-up
with noninvasive duplex scan derived graft flow velocities
is obtained at 1 month, every 3 months for the first 18
months, and then every 6 months after this. Interven-
tions for failing bypass grafts (isolated graft flow velocity
300 cm/s and distal velocities45 cm/s) are recorded
in the database. Patients receiving all other types of
revascularization (aortoiliac open reconstruction, and all
endovascular intervention) are followed-up with a pa-
tient visit and a noninvasive vascular study at 1 month
and then at 6-month intervals.
The database information is updated with each visit. In
addition, the database has been scrutinized each summer by
independent research workers looking for missing data points
or missing patients. Sources used to attain follow-up include
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puterized radiology Picture Archiving Communication Sys-
tem, and the online obituary services of all statewide newspa-
pers.
To date, 1600 revascularizations and 600 major
lower extremity amputations have been entered into the
database and monitored for functional outcome and living
status. As a result of these follow-upmethods, 73 of the 841
patients studied were lost to follow-up. For the purpose of
the life tables, patients lost to follow-up were censored at
the last confirmed follow-up date. At the end of 60months,
75 patients were left for analysis.
Statistical analysis. Kaplan-Meier survival curves were
used to assess reconstruction patency, limb salvage, sur-
vival, maintenance of functional ambulatory status, and
maintenance of independent living status over time. The
proportional hazards assumption was tested for each plot
and found to be appropriate. The log-rank test was used to
assess differences in these curves. All factors significantly
associated with time to measured event (thrombosis, limb
loss, death, loss of ambulation, or loss of independence) in
bivariate analysis were then entered into a Cox proportional
hazards model. Backward stepwise elimination was used to
remove nonsignificant factors from the model. Hazard
ratios (HR) and 95% confidence intervals from the final
model were used to describe event time risk. All analyses
were conducted using SAS 8 software (SAS Inc, Cary, NC).
Values of P  .05 were considered indicative of statistical
significance.
RESULTS
The overall results for the technical measures of arterial
reconstruction patency and limb salvage using Kaplan-
Meier life table curves are shown for the entire cohort in
Figs 1 and 2. The mean age for the cohort was 68.1  12.1
years (range, 29 to 97 years). The mean  standard devia-
tion follow-up was 27.5  21.6 months, and median
Fig 1. Kaplan-Meier life tables show the overall secondary pa-
tency in 1000 revascularized limbs. Whiskers represent 95% confi-
dence intervals.follow-up was 24months (range, 0 to 89months) for 1931person-years of follow-up; 75% of patients had 1 year of
follow-up. The overall 5-year secondary patency was 72.4%
and the limb salvage rate was 72.1% (ie, the percentage of
patients with a patent reconstruction and an intact limb at
the time of functional outcome assessment).
The log-rank test showed there were no statistically
significant differences in the Kaplan-Meier curves analyzing
secondary patency for all endovascular procedures vs all
open procedures vs both: 1-year patency was 76.6% (71.5,
81.0) vs 82.7% (79.3, 85.6) vs 72.9% (51.2, 86.2). There
was also no difference in limb salvage for endovascular
procedures vs open procedures vs both: 1-year limb salvage
was 76.5 % (71.8, 81.3) vs 82.4% (79.3, 85.5) vs 72.9%
(55.6, 90.2). There was, however, a statistically significant
better secondary patency rate for patients receiving aor-
toiliac intervention vs infrainguinal intervention, with a
1-year patency of 89.0% (84.1, 92.5) vs 77.9% (74.4, 80.9)
(P  .0001). There was also statistical significance with
1-year limb salvage for patients receiving aortoiliac inter-
vention vs infrainguinal intervention (87.3% vs 78.3%; P
.0002) and for patients receiving aortoiliac open interven-
tion vs patients receiving an infrainguinal endovascular
intervention (94.4% vs 75.3%, P  .0033).
Cox proportional hazards models were used to derive
preoperative factors independently associated with recon-
struction thrombosis and limb loss. Patients with gangrene
(1-year secondary patency, 66.7%; HR, 2.05, P  .001),
impaired preoperative ambulatory status (1-year secondary
patency for nonambulatory/homebound, 64.8%; HR,
1.66; P  .002), or ESRD (1-year secondary patency,
57.5%; HR, 2.64; P  .001) had significantly lower sec-
ondary patency. Patients presenting with gangrene (1-year
limb salvage, 66.7%; HR, 1.78; P  .0019), diabetes
(1-year limb salvage, 74.8%; HR, 1.40; P  .0357), end-
stage renal disease (1-year limb salvage, 57.3%;HR, 2.51;P
.0001), multilevel arterial disease (1-year limb salvage, 71.7%;
Fig 2. Kaplan-Meier life tables show the overall limb salvage in
1000 revascularized limbs. Whiskers represent 95% confidence
intervals.HR, 2.67; P .0015), or significantly impaired preoperative
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homebound, 67.0%; HR, 1.79; P  .0003) had signifi-
cantly lower limb salvage rates.
Overall results for survival, maintenance of ambulation,
andmaintenance of independent living using Kaplan-Meier
life-table curves are shown for the entire cohort in Figs 3, 4,
and 5, respectively. Table I displays the results for each
outcome by each of the predictive variables and log-rank
P values. At 5 years, overall survival was 41.9%, mainte-
nance of ambulation was 70.6%, and maintenance of inde-
pendent living status was 81.3%.
When mortality was examined, preoperative factors
found not to be statistically significant in determining late
mortality included gender (P  .758), hypertension (P 
.402), obesity (P  .435), and prior vascular surgery (P 
.742). Cox proportional hazards models were used to
Fig 3. Kaplan-Meier life tables show the cumulative survival in
841 patients who underwent 1000 limb revascularizations. Whis-
kers represent 95% confidence intervals.
Fig 4. Kaplan-Meier life tables showing cumulative maintenance
of ambulation in 841 patients who underwent 1000 limb revascu-
larizations. Whiskers represent 95% confidence intervals.derive preoperative factors independently associated withdeath (Table II). In decreasing order of influence they
include nonambulatory/transfer-only status (1-year sur-
vival, 90%; HR, 3.45), end-stage renal disease (1-year sur-
vival, 67.1%; HR, 2.25), age 70 (1-year survival, 79.7%;
HR, 1.85), COPD (1-year survival, 73.8%; HR, 1.76), the
dementia (1-year survival, 55.4%; HR, 1.57), and coronary
disease (1-year survival, 75.9%; HR, 1.45). Limb loss 1
year of intervention was not a statistically significant deter-
minant of mortality.
Factors found not to be statistically significant in deter-
mining maintenance of ambulation included age (P 
.099), race (P  .454), history of smoking (P  .065),
hypertension (P  .282), obesity (P  .356), COPD (P 
.718), prior vascular surgery (P  .207), or the type of
vascular intervention (endovascular vs open surgery) (P 
.063). Cox proportional hazards models were used to
derive factors independently associated with deterioration
of ambulatory status postoperatively (Table III). In de-
creasing order of influence they include limb loss 1 year
(ambulatory maintenance at 1 year, 47.9%; HR, 6.75),
ambulatory/homebound status (ambulatory maintenance
at 1 year, 63.8% HR, 3.01), the dementia (ambulatory
maintenance at 1 year, 67%; HR, 2.01), end-stage renal
disease (ambulatory maintenance at 1 year, 73.6%; HR,
1.25), female gender (ambulatory maintenance at 1 year,
85.9%; HR, 1.59), and the presence of diabetes (ambula-
tory maintenance at 1 year, 81.1%; HR, 1.44).
When maintenance of independence was examined, 23
patients who were already in nursing homes before their
arterial intervention were excluded from analysis. Factors
found not to be statistically significant in determining
maintenance of independent living status in the remaining
patients included race (P  .196), gender (P  .108),
diabetes (P  .051), hypertension (P  .187), hyperlip-
idemia (P  .18), cerebrovascular disease (P  .070),
Fig 5. Kaplan-Meier life tables showing cumulative maintenance
of independent living status in 841 patients who underwent 1000
limb revascularizations. Whiskers represent 95% confidence inter-
vals.prior vascular surgery (P  .402), or the type of vascular
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Patient characteristic
Survival Ambulatory status Independent living
Patients at
risk (n) Died (%)
Patients at
risk (n)
Failed
ambulation (%)
Patients at
risk (n)
Failed independent
living (%)
Age group
50 69 27.5 69 21.7 69 5.8
50-59 136 33.1 136 14.7 134 5.2
60-69 220 36.8 220 20.5 218 10.6
70-79 262 50.8 262 21.0 252 16.3
80 154 48.1 154 24.0 145 18.6
Log-rank P .01 .10 .01
Race
White 640 56.3 640 19.1 623 11.2
Black 194 36.6 194 25.3 188 17.0
Other 7 14.3 7 14.3 7 0
Log-rank P .04 .45 .20
Gender
Male 479 41.3 479 16.5 471 10.4
Female 362 42.5 362 25.7 347 15.3
Log rank P .76 .01 .11
Presentation
Rest pain 341 39.0 341 15.8 337 10.1
Ulceration 308 41.6 308 18.2 294 9.2
Gangrene 192 47.4 192 32.3 187 21.9
Log-rank P .02 .01 .01
Diabetes
No 385 36.1 385 14.0 376 10.1
Yes 456 46.7 456 25.9 442 14.5
Log-rank P .01 .01 .05
Smoking status
Never 278 39.9 278 23.7 267 14.2
Former 218 50.9 218 21.1 212 16.0
Current 345 37.7 345 17.4 339 8.8
Log-rank P .01 .07 .01
ESRD
No 633 36.8 633 16.0 619 10.2
Insufficiency 106 50.0 106 29.2 102 16.7
Yes 102 64.7 102 39.2 97 22.7
Log-rank P .01 .01 .01
CAD
No 362 30.9 362 17.1 355 9.3
Yes 479 50.1 479 23.0 463 14.9
Log-rank P .01 .01 .01
Hypertension
No 159 40.9 159 18.2 153 9.8
Yes 682 42.1 682 21.0 665 13.1
Log-rank P .40 .28 .19
Hyperlipidemia
No 536 45.0 536 22.6 519 13.7
Yes 305 36.4 305 16.7 299 10.4
Log-rank P .05 .04 .18
Obesity
No 711 42.8 711 21.1 688 13.7
Yes 130 36.9 130 16.9 130 6.2
Log-rank P .44 .36 .03
COPD
No 665 36.7 665 20.8 646 11.0
Yes 176 61.4 176 19.3 172 18.0
Log-rank P .01 .72 .01
CVA
No 686 39.9 686 19.1 670 11.2
Yes 155 50.3 155 26.5 148 18.2
Log-rank P .01 .01 .01
CVD
No 621 39.6 621 18.8 608 11.7
Yes 220 48.2 220 25.0 210 14.8
Log-rank P .01 .01 .07
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(P  .171). Cox proportional hazards models were used
to derive factors independently associated with deterio-
ration in independent living status postoperatively (Ta-
ble IV). In decreasing order of influence they include
nonambulatory/transfer status (maintenance of inde-
pendent living status at 1 year, 68.7%; HR, 6.05), the
presence of dementia (maintenance of independent liv-
ing status at 1 year, 58.7%; HR, 5.95), ambulatory/
homebound status (maintenance of independent living
status at 1 year, 66.8%; HR, 3.77), age 70 to 79 (main-
tenance of independent living status at 1 year, 89.1%;
HR 3.42), limb loss within 1 year (maintenance of
independent living status at 1 year, 77.3%; HR 3.24), age
greater than 80 (maintenance of independent living sta-
tus at 1 year, 87%; HR, 3.09), and history of a stroke
(maintenance of independent living status at 1 year,
86.6%; HR, 1.9).
DISCUSSION
The purpose of this study was twofold. First, we at-
tempted to determine the importance of limb salvage on
the ultimate functional outcome of patients undergoing
operative treatment for critical limb ischemia secondary to
Table I. Continued.
Patient characteristic
Survival
Patients at
risk (n) Died (%)
Patie
risk
Dementia
No 773 39.1 77
Yes 68 73.5 6
Log-rank P .01
Prior vascular
procedure
No 550 42.0 55
Yes 291 41.6 29
Log-rank P .74
Ambulation
Ambulatory 664 34.5 66
Homebound 147 69.4 14
Transfer 30 70.0 3
Log-rank P .01
Living status
Independent 809 40.7 80
Assisted 9 66.7
Nursing home 23 73.9 2
Log-rank P .01
Intervention
Endovascular 302 40.4 30
Open Surgery 513 41.9 51
Both types 26 57.7 2
Log-rank P .01
Limb loss  1st yr
No 670 38.8 67
Yes 171 53.8 17
Log-rank P .01
ESRD, End-stage renal disease; CAD, coronary artery disease; COPD,
cerebrovascular disease.peripheral arterial disease of the lower extremities. Second,we attempted to assess what other factors may be of impor-
tance in determining functional outcome after intervention.
This was done by retrospectively reviewing 22 perioperative
variables, including amputation 1 year of intervention. We
found that limb loss did indeed result in significant func-
tional impairment, thus confirming the intuitive impor-
tance of limb salvage surgery. Limb loss, however, was not
the only variable found to be an important determinant of
functional outcome.
Our study measured functional outcome using the
three parameters of survival, maintenance of ambulation,
and maintenance of independent living status. These pa-
rameters were chosen because they represent anticipated
benefits one would intuitively expect after lower extremity
revascularization. Too often our literature has chosen to
report end points of success that are probably more impor-
tant to surgeons than to patients. These technical end
points, which include jargon such as primary patency, as-
sisted primary patency, and secondary patency, are useful to
the craftsmen who perform the procedures; however, pa-
tients and the payers are usually more interested in answers
to basic concerns. Will this procedure make me walk better
and will it keep me out of the nursing home? On examina-
tion of the data, we found that improvement after interven-
bulatory status Independent living
Failed
ambulation (%)
Patients at
risk (n)
Failed independent
living (%)
18.6 762 10.0
41.2 56 46.4
.01 .01
18.9 533 11.6
23.4 285 14.0
.21 .40
16.6 663 7.8
39.5 135 32.6
13.3 20 30.0
.01 .01
20.1 809 12.2
0 9 33.3
39.1 –n/a– –n/a–
.01 .01
20.9 288 12.2
20.5 505 12.3
15.4 25 20.0
.06 .17
10.9 655 8.5
42.1 163 28.2
.01 .01
ic obstructive pulmonary disease; CVA, cerebrovascular accident; CVD,Am
nts at
(n)
3
8
0
1
4
7
0
9
9
3
2
3
6
0
1
chrontion (ie, improving from ambulatory homebound to ambu
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back to home) rarely occurred. It became obvious that our
best hope for success inmany of these patients was simply to
Table II. Cox proportional hazards model results for
time to death after revascularization
Patient characteristic HR estimates (95% CI) P
Age group
50 Referent .26
50-59 1.36 (0.80, 2.34) .24
60-69 1.36 (0.82, 2.25) .01
70-79 1.85 (1.13, 3.04) .03
80 1.81 (1.07, 3.09)
Race
White Referent —
Black 0.72 (0.55, 0.95) .02
ESRD
No Referent —
Insufficiency 1.25 (0.92, 1.71) .16
Yes 2.25 (1.66, 3.06) .01
CAD
No Referent —
Yes 1.45 (1.14, 1.84) .01
COPD
No Referent —
Yes 1.76 (1.38, 2.24) .01
Dementia
No Referent —
Yes 1.57 (1.13, 2.17) .01
Ambulation
Ambulatory Referent —
Homebound (1.77, 3.05) .01
Transfer 3.45 (2.18, 5.56) .01
HR, Hazard ratio; CI, confidence intervals; ESRD, end-stage renal disease;
CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease.
Table III. Cox proportional hazards model results for
analysis of ambulatory deterioration/failure after
revascularization for time to ambulation failure
Patient characteristic HR estimates (95% CI) P
Sex
Male Referent —
Female 1.59 (1.17, 2.15) .01
Diabetes
No Referent —
Yes 1.44 (1.03, 2.012) .03
ESRD
No Referent —
Insufficiency 1.67 (1.10, 2.52) .02
Yes 1.25 (0.80, 1.95) .32
Dementia
No Referent —
Yes 2.01 (1.24, 3.23) .01
Ambulation
Ambulatory Referent —
Homebound 3.01 (2.12, 4.27) .01
Transfer 0.91 (0.33, 2.51) .86
Limb loss 1st year
No Referent —
Yes 6.75 (4.88, 9.33) .01
HR, Hazard ratio; CI, confidence intervals; ESRD, end-stage renal disease.prevent deterioration in functional status.Even when we lowered our expectations, we found
deterioration occurred in several patient groups with spe-
cific comorbidities despite successful revascularization. Of
all perioperative comorbidities examined, 12 were found to
independently predict poorer outcome in at least one pa-
rameter measured. Only two variables independently pre-
dicted poorer functional outcome in all three categories:
preoperative dementia and impaired ambulatory status at
the time of presentation for arterial intervention. Three
variables were independently associated with poorer func-
tional outcome in two functional outcome parameters: old
age (75 years), limb loss 1 year of intervention, and
end-stage renal disease. Seven variables were independently
associated with poorer functional outcome in one category,
three associated with increased mortality (the presence of
coronary artery disease, COPD, and African American eth-
nicity), two associated with loss of ambulation (diabetes
and female gender), and two associated with loss of inde-
pendence (gangrene and history of stroke).
Although hazard ratios showed that amputees had a
sixfold greater chance of not ambulating and a threefold
greater chance of losing their independence, they experi-
enced no decrease in survival. This contrasts with patients
who presented with impaired ambulatory status and de-
mentia preoperatively. These patients not only experienced
a twofold to threefold risk of ambulatory deterioration and
a sixfold risk of losing their independent living status, but
they also experienced a 1.5-fold to threefold risk of mortal-
ity compared with referent controls. Other high-risk
Table IV. Cox proportional hazards model showing
preoperative factors associated with failure in
independent living
Patient characteristic HR estimates (95% CI) P
Age group
50 Referent —
50-59 1.04 (0.30, 3.56) .96
60-69 1.82 (0.62, 5.35) .28
70-79 3.42 (1.21, 9.71) .02
80 3.09 (1.04, 9.16) .04
Presentation
Rest pain Referent —
Ulceration 0.57 (0.33, 0.97) .04
Gangrene 1.47 (0.90, 2.39) .13
CVA
No Referent —
Yes 1.90 (1.20, 3.00) .01
Dementia
No Referent —
Yes 5.95 (3.64, 9.72) .01
Ambulation
Ambulatory Referent —
Homebound 3.77 (2.36, 6.03) .01
Transfer 6.05 (2.45, 14.95) .01
Limb loss within 1st year
No Referent —
Yes 3.24 (2.14, 4.93) .01
HR,Hazard ratio; CI, confidence intervals; CVA, cerebrovascular accident.groups included elderly patients, who had a twofold higher
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dence, and patients with end-stage renal disease, who had a
twofold higher risk of mortality and a 1.25 greater risk of
losing independence.
The findings of this study suggest that some patients
who present with limb threatening ischemia, meet every
classic indication for intervention, and may have a success-
ful procedure with satisfactory technical outcome, includ-
ing limb salvage, will experience no functional benefit.
These are patients with dementia and impaired ambulatory
ability at presentation. They are more prone to death,
ambulatory failure, and loss of independence than all other
groups observed, even the cohort of patients who lose their
limbs. These findings challenge the cognitive foundation of
any vascular surgeon, a foundation that states it is accept-
able to attempt lower extremity revascularization on any
patient who shows aptitude toward ambulation and who is
capable of surviving intervention. This report suggests we
need to reconsider our position.
It is important to recognize the social backdrop in
which this study has been performed. In 2006, the first of
the baby-boomers will turn 60 years old. If one uses con-
servative census figures with atherosclerotic prevalence
data, we can expect a 66% increase in patients presenting
with peripheral arterial disease of the lower extremities
during the next 10 years.9 In addition, patients are living
longer with coexisting chronic diseases such as end-stage
renal disease. Thus, they present for medical treatment of
routine illnesses at advanced age with impaired physiology.
Couple this with the looming financial crisis that faces
medicine, and one can see that our current medical system
will not have the resources available to treat all patients who
present, especially those with degenerative diseases attrib-
utable to aging. Rationing of care, when it occurs, will
probably be economically driven. Treatment may be avail-
able, but not “covered” by the third-party payer. It can be
imagined that expensive treatment such as intervention for
peripheral arterial disease will receive close scrutiny and will
most likely be reserved for patients whose therapy has
proven functional benefit—a benefit capable of promoting
independence and avoidance of expensive institutional
skilled nursing care. Studies that help define cost-efficient
delivery of health care are desperately needed.
With this in mind, we sought to determine whether our
interventions maintained ambulation and independence, a
totally different perspective from vascular conventional wis-
dom where patency still reigns as king. Patency in this
report was used only as a frame of reference for considering
functional outcome, meaning, was the arterial reconstruc-
tion open andworking at the time of functional assessment?
The use of ambulation and independence as end points
radically changes our definition of success. For example,
major limb amputations with prosthetic rehabilitation are
no longer measures of failure but are considered measures
of success. This may represent heresy to many vascular
surgeons, but we suspect payers may not consider it with
such disdain.Our study was not designed to examine the natural
history of untreated critical ischemia as it pertains to main-
tenance of ambulation and independence, and thus it is
conceivable that functional performance would have been
significantly worse without vascular intervention. It was a
retrospective study performed at a single center. The type
of treatment performed was left to the discretion of the
treating physician and was not controlled. Although it
identified groups of patients who did poorer than the
referent population (patients such as older demented indi-
viduals with impaired preoperative functional status or end-
stage renal disease), it falls short of providing helpful con-
crete recommendations for how to treat poor performers.
It cannot be concluded that all of the identified high-risk
patients will do poorly. Examining the data in this report
shows only that a higher percentage of patients in these
high-risk groups performed worse than their referent co-
hort. Some patients in these groups performed well.
Despite these limitations, our report is a large
population-based study from the only group of vascular
specialists within a referral basin of 1 million people. We
have concluded that when the major goal of therapy is
maintenance of ambulation and independence, some pa-
tients will not be helped with revascularization. These
patients are often experiencing a systemic deterioration at
the end stages of life andmay represent up to 20% to 25% of
people, as was the case in our series, who present with
symptoms of critical limb ischemia. In these cases, toe
gangrene may be the inciting event that motivates the
patient to seek care, but treating this is the equivalent of
repairing a light bulb on a sinking ship. Further prospective
study to determine characteristics attributable to patients
who eventually performed well and characteristics of those
who eventually performed poorly are needed prior to any
consideration of rationing of care.
CONCLUSION
Functional outcomes such as survival, maintenance of
ambulation, and independent living after intervention for
critical limb ischemia of the lower extremities are not solely
determined by the classic outcome measures of interven-
tion patency and limb salvage. There are additional intrinsic
patient comorbidities at the time of presentation that are
equally reliable determinants of functional outcome. Spe-
cifically, this report questions our conventional approach to
critical limb ischemia in patients who are mentally and
functionally impaired or who have chronic degenerative
diseases such as end-stage renal disease, patients who un-
doubtedly will be more prevalent as our population ages.
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Dr John Eidt (Little Rock, Ark). I would like to extend my
congratulations to Dr. Taylor for a wonderful presentation. It is an
important topic and I think it is timely, and I want to thank him
and his coauthors for getting me a copy of this data-packed
manuscript a week ago, and even though I’ve had a week, I still
haven’t really scratched the surface. There is a lot of information
here, and when this gets published you really need to read this
because I think it has a lot of important data.
I’d like to emphasize this is a review of 1000 consecutive
procedures. It is not selected, and no claudicants are included in
this. They have been treated by one of the most well-respected
groups of vascular surgeons in the south and they have used
state-of-the-art open and endovascular techniques. These results
are assuredly as good or better than certainly in our practice, and
I’m sure in many of our practices.
The study is somewhat limited by the fact that it is retrospec-
tive and much of the data is dependent on the correct input of
diagnoses codes at hospital level. For example, I find it a little hard
to believe that 31% of these patients living in the heart of tobacco
country were recorded as never using tobacco. These limitations
are overcome to some degree by the sheer size of the database.
Rather than focusing on traditional end points of graft patency
and limb salvage that have become the sort of holy grail of vascular
surgery, Dr Taylor and his colleagues have tried to answer a more
philosophical question: does vascular intervention really improve
our patients’ lives? Sadly, it appears that in many cases, vascular
intervention may be fruitless and in some cases even harmful. It
may be that we just focus too much on limb salvage and patency
and too little attention on functional outcome. It looks like in
about a third of these patients, vascular intervention, regardless of
open or endovascular, was really of limited value as measured by
functional outcome. I have three questions.
The first question is, the average age was 68 years. You showed
that at 5 years only 40% or so of these patients were alive, about
70% were ambulatory, and 80% were living independently. Do you
have any idea how this compares to an age-matched control group?
In other words, are we improving or are we making these people’s
lives actually worse?
Second, I recall that John Porter, the late John Porter, from
Portland, presented data a few years ago that showed that vascular
surgery had little impact really on ambulatory status. He found that
nonambulatory patients usually remained nonambulatory after
vascular surgery and likewise that ambulatory patients tended tohave sort of focused on the downside of your data but I wonder
were you able to identify factors that were predictive of improved
ambulatory status or return to baseline? In other words, how dowe
better select people we should treat because we are going to
improve their ambulatory status?
Finally, I had a well-educated patient that survived a fem-pop
bypass, a follow-up fem-tib bypass, a bypass revision, and eventual
amputation. When I saw him several years later at a cocktail party
he told me that if he had realized how good it was to have an
amputation he would never have consented to bypass surgery. You
showed that two factors in particular had a greater impact on
long-term functional outcome than even amputation itself and that
was impaired ambulatory status at the time of presentation and
dementia. Has your practice been changed by your data to include
more primary amputations, particularly in the demented bed-
bound nursing home patient?
Again, I want to congratulate you for undertaking this ardu-
ous ask of honestly looking at your results. These types of results
will I am sure be very important to those responsible for financing
health care in this country, and I would like to thank again the
organization for the privilege of initiating the discussion of this
paper.
Dr Taylor. John, in terms of cigarette smoking, you know Dr
Debakey, I think, or I think it was D. Crawford, used to say that
everybody with an aneurysm was either a smoker, a past smoker, or
a liar. I’m sure that we probably missed a few of the cigarette
smokers in 31%.
Age-matched control is a great question. I think the previous
presentation is very eye opening. Maybe what we need to do with
the last lady that I showed on the slide is send her to the wound
care center and see if we can nurse her through all those. While Dr
Marston was down on himself saying that taking care of patients
for a year with a wound is—I would argue that is probably a very
acceptable alternative. You can keep this lady in her functional state
at the nursing home and being able to do what she has been doing.
Age-matched control is a great question, and I think you heard
some data in the previous presentation that would be insightful
regarding that.
Who improved? Theoretically you would think that when
somebody comes with a bad leg and you are operating on a bad leg
they should get better or you should see improvement, but in
reality when we looked at the LEGS data, which is the data that we
found, we found this was unusual. It was very, very unusual to see
people go from a classification as we classified as ambulation up to an
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It was so rare that we did not look at it in this study, but we can
certainly do it and probably by the time the manuscript is pub-
lished, we could probably put it in, and I apologize, I don’t know
the numbers but it is a very unusual occurrence. We typically—I
believe your best chance (I agree with Dr Porter)—is to probably
hope to get or achieve maintenance of your current level of
function.
Has this changed our practice? It is impossible not to know the
information that we know and not let it subconsciously work into
the way you manage patients. I will say this though, we are as
aggressive as ever. Patients still get referred for revascularization.
They don’t want to hear that they are going to lose their leg. We
still try, but I will tell you, we need to look at it and we need to start
thinking about what’s the right thing to do in light of this and I
think it has and will eventually change our practice.
Dr Thomas Brothers (Charleston, SC). Dr Taylor, I want to
lend my congratulations to an excellent presentation. I wonder if
you would also agree that freedom from pain and also preserving a
sense of body wholeness are other worthwhile goals that we might
strive to achieve and ask whether or not you might consider
including those elements of overall quality of life at least equally as
important as level of functionality as you review your results.
Dr Taylor.We stayed with the parameters that we have stayed
with. Your partner and I, Dr Robertson, were talking yesterday.
Functional outcomes you can define in a lot of different ways.
Being able to stand, to dress. Is that an important thing? Bodily
wholeness, freedom from pain—no question about it. These are
indications, these are parameters that I would argue probably need
to be looked at more so than patency. Of course we don’t have
those data, but it is clearly something that would be worthwhile to
look at.
Dr James Seeger (Gainesville, Fla). It is just a little bit of a
different spin on this that I would ask you to look at and that is that
you looked at the predictors of poor outcome, but you didn’t look
at the predictors of good outcome. Most of us would assume thatgood outcome from the patient’s point of view is that they are
alive, walking around, and at home. Although we sort of think we
can predict those people, the two questions I would have are what
percentage of the patients achieved that outcome, all three good
outcomes, and then did you have any predictors of that group of
patients in which it would be no question that they should have a
procedure?
Dr Taylor. Well you know you can flip our Cox models
around and basically you are half full or half empty. You’re right,
we have taken a pessimistic approach to this, and I think it is biased
upon the last case I presented. I don’t know about you—I know
you are down in Florida, just as we are. You are inundated with
these difficult, difficult patient decisions and you go home and you
feel like you haven’t helped anybody and in reality the sobering fact
is we probably haven’t helped as many people as we did 10 years
ago when I was in the Air Force working with Dr Mills, so it is a
reality. The flip side, the paper that we have on for Saturday, the
people we probably help more than anything are claudicants. We
probably—you had to admit it that the cardiologists may be onto
something that we are not, but we probably should—the people
that you are going to get the most functional benefit in, and I think
there have been data that have been shown certainly at North-
western and others, is you are going to help the claudicants, get
them back working again, and we probably undertreat claudication
in my opinion only, my opinion, and probably overtreat limb-
threatening ischemia, but you need data like this to kind of see
what is what. Not everybody that was end-stage renal disease or not
everybody that had poor function did poorly. Which patients did
poorly and which patients didn’t do poorly?Why did some dowell?
These are the questions. This study wasn’t really very helpful at the
bedside but it certainly tells areas where we need to go to work at
the bedside to find out exactly which patients need to be revascu-
larized and which ones do you not treat and which ones you send
to Dr Marston for the wound care clinic. I think there is a lot of
work that needs to be done.
